| ||||||||||||||
|
|
|||||||||||||



*Department of Cardiovascular Anesthesiology and
The Cullen Cardiovascular Surgical Research Laboratories, Texas Heart Institute at St. Lukes Episcopal Hospital, Houston, Texas
Address correspondence and reprint requests to Dr. Nussmeier, Department of Cardiovascular Anesthesiology, Texas Heart Institute at St. Lukes Episcopal Hospital, PO Box 20345, MC1-226, Houston, TX 77030. Address email to nnussmeier{at}heart.thi.tmc.edu
The Jarvik 2000 HeartTM is a left ventricular assist device that produces continuous nonpulsatile axial flow by means of a single, rotating, vaned impeller. Anesthetic and perioperative considerations of the Jarvik 2000 HeartTM differ from those of conventional assist devices. The Jarvik 2000 is implanted within the left ventricle through a left thoracotomy, which is aided by left lung isolation. A brief period of cardiopulmonary bypass and induced ventricular fibrillation facilitate implantation. Transesophageal echocardiography is essential to assure proper intraventricular positioning of the device and aortic outflow, confirmed by observation of aortic valve opening in the presence of adequate left ventricular volume. Because continuous flow devices function best in the presence of lower systemic and pulmonary vascular resistance, milrinone was preferentially used as an inotropic drug. In the first group of 10 patients to receive the Jarvik 2000, the pump provided a cardiac output of up to 8 L/min, depending on preload, afterload, and pump speed. There were no early perioperative deaths. The average support duration was 81.2 days; the range was 13214 days. Seven of the 10 patients survived to transplantation. Survivors underwent complete physical rehabilitation during pump support.
IMPLICATIONS: The Jarvik 2000 is a left ventricular assist device that produces continuous nonpulsatile axial flow by means of a rotating, vaned impeller. Because the anesthetic considerations differ from those of conventional left ventricular assist devices, we report the perioperative management of the first 10 patients who participated in a bridge-to-transplantation feasibility study of the Jarvik 2000.
This article has been cited by other articles:
![]() |
S. Chumnanvej, M. J. Wood, T. E. MacGillivray, and M. F. V. Melo Perioperative Echocardiographic Examination for Ventricular Assist Device Implantation Anesth. Analg., September 1, 2007; 105(3): 583 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Scolletta, I. D Gregoric, L. Muzzi, B. Radovancevic, and O H. Frazier Pulse wave analysis to assess systemic blood flow during mechanical biventricular support Perfusion, January 1, 2007; 22(1): 63 - 66. [Abstract] [PDF] |
||||
![]() |
I. El-Magharbel Ventricular Assist Devices and Anesthesia Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2005; 9(3): 241 - 249. [Abstract] [PDF] |
||||
|